Comparison of the two treatment modalities (crystallized phenol application vs. surgical treatment) for pilonidal sinus disease
Comparison of crystallized phenol application and surgery on quality of life and pain in patients for pilonidal sinus disease
Kamil Gulpinar
150 participants
Jun 15, 2012
Interventional
Conditions
Summary
Pilonidal sinus disease is an acquired disease at the sacrococcygeal region that can be treated by a number of surgical techniques. Crystallized phenol application seems to be an alternative therapy for pilonidal sinus disease with higher success rates, lower costs, faster recovery and earlier return to work. The aim of this presentation is to compare the crystallized phenol application and surgery for pilonidal sinus disease .
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients were randomized to 2 groups according to applied treatment protocol Group 1: Crystallized phenol will be applied into pilonidal sinus tract. The amount of the crystallized phenol will differ according to the patients sinus tract. the patient will be followed for three weeks for wound healing. Closure of the sinus tract in three weeks will be accepted as cure. In case of failure in the healing of sinus tract in three weeks, the crystallized phenol application will be performed respectively. Group 2: Surgical technique either primary closure or marsupialization will be performed. primary closure for patients who does not have infection on the surgical site and marsupialization for patients who had acute infection on surgical site were the reason for surgery technique . For both techniques the duration of surgery were estimated as 1 hour. The patients follow up will continue until the full wound healing occurs.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12612000868886